| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_27a71ddaaa2f5a8c228fc6cb3f3b3098 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2007-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_105f31c5aff74a353468dafc5501266f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87192f4b71474959cb96ccf59f6db125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84c95eb31656d5b792d7b74705353b9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ff13e6d79a28a307f47d2bfa4820d22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d7ba758af443429e5cfd417d3d20e62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce1294ebc74a017d4af9698e3d9eb1c0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef81b3dbdea72f70ad95c1142c38cdb9 |
| publicationDate |
2011-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-015654-B1 |
| titleOfInvention |
ANTIBODIES AGAINST BETA AMYLOID PEPTIDE |
| abstract |
Disclosed are antibodies that bind a human β-amyloid peptide; methods for treating diseases or disorders characterized by elevated levels of β-amyloid or deposits of β-amyloid with said antibodies; pharmaceutical compositions containing these antibodies; and methods for producing antibodies. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2746325-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11530257-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2509155-C1 |
| priorityDate |
2006-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |